Search Result "CLL)"
Novel Insights in Molecular Mechanisms of CLL
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 23 Year: 2012 Page: 3363-3372
Author(s): Nicola Zanesi,Veronica Balatti,Arianna Bottoni,Carlo M. Croce,Yuri Pekarsky
Targeting Bcl-2 in CLL
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 30 Year: 2012 Page: 5109-5115
Author(s): M. Rogalinska,Z.M. Kilianska
The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 23 Year: 2012 Page: 3335-3355
Author(s): Laurens P. Kil,Saravanan Yuvaraj,Anton W. Langerak,Rudi W. Hendriks
Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2017 Page: 102-114
Author(s): Ida Franiak-Pietryga,Ewelina ZióÅkowska,Barbara Ziemba,Dietmar Appelhans,Henryk Maciejewski,Brigitte Voit,Aleksandra Kaczmarek,Tadeusz Robak,Barbara Klajnert-Maculewicz,Barbara Cebula-Obrzut,Piotr Smolewski,Maciej Borowiec,Maria Bryszewska
Studying of the CLL After Treatment Using Fractal Parameter of Neoplastic Lymphocytes Detection (λnld)
Ebook: Topics in Anti-Cancer Research
Volume: 10 Year: 2021
Author(s): Zahra Rostami,Mohammad Reza Rezaei
Doi: 10.2174/9789815039290121100004
Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Journal: Current Drug Delivery
Volume: 9 Issue: 1 Year: 2012 Page: 30-40
Author(s): Aisha Masood, Mohammad A. Shahshahan, Ali R. Jazirehi
Re-Establishment of a Normal Apoptotic Process as a Therapeutic Approach in B-CLL
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3 Issue: 4 Year: 2003 Page: 261-286
Author(s): Jean-Pierre Kolb, Catherine Kern, Claire Quiney, Viviana Roman, Christian Billard
Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 7 Year: 2010 Page: 716-727
Author(s): R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke, K.-A. Kreuzer
Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 510-518
Author(s): G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta, V. Gattei